Run-Bin Liang

Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy <i>versus</i> lenvatinib alone for advanced hepatocellular carcinoma

Minke He, Run-Bin Liang, Yang Zhao et al. · Therapeutic Advances in Medical Oncology · 2021 · 214 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Comparison of HBV reactivation between patients with high HBV-DNA and low HBV-DNA loads undergoing PD-1 inhibitor and concurrent antiviral prophylaxis

Minke He, Chuan Peng, Yang Zhao et al. · Cancer Immunology Immunotherapy · 2021 · 38 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Modification of Pathologic T Classification for Non-small Cell Lung Cancer With Visceral Pleural Invasion

Run-Bin Liang, Li Peng, Bob T. Li et al. · CHEST Journal · 2021 · 27 citations · Full text

Medicine, Oncology, Pathology +13

Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular Carcinoma

Run-Bin Liang, Yang Zhao, Minke He et al. · Frontiers in Oncology · 2021 · 20 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma

Yang Zhao, JiaYing Lai, Run-Bin Liang et al. · Journal of interventional medicine · 2019 · 10 citations · Full text

Medicine, Oncology, Pharmacotherapy +17